Intellectual Property

The U.S. FDA recently approved Genentech’s Phesgo for the treatment of early and metastatic HER2-positive breast cancer, in combination with chemotherapy.  Phesgo is a fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase, administered via subcutaneous injection. Fujifilm Kyowa Kirin Biologics recently announced that it received approval in Japan for its adalimumab product, the first adalimumab biosimilar to Abbvie’s Humira® approved in Japan.  Commercialization of the product will be handled by Fujifilm’s partner, Mylan.   The post…
What Happens if Reasonable Minds Could Disagree Whether Information in a Copyright Registration Is “Inaccurate”? Last time, I wrote about an outrageous legal result, Unicolors v. H & M. Because the copyright holder made a ministerial (i.e., minor) mistake on its copyright registration application form, it had a very large judgment for copyright infringement thrown out. It had won at trial, been awarded money damages by a jury, then been awarded its attorneys’…

Intellectual Property Blogs